Similar Papers

Paper Title
Journal
Date
Author
Efficacy of Cariprazine in the Psychosis Spectrum: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials in Schizophrenia and Bipolar Disorder.
Livio Tarchi ... Giovanni Castellini
CNS drugs | VOL. 38
Livio Tarchi, et. al.Livio Tarchi ... Giovanni Castellini
09 Oct 2024
Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials.
André Do ... Ayal Schaffer
Frontiers in Psychiatry | VOL. 12
André Do, et. al.André Do ... Ayal Schaffer
14 Dec 2021
Polygenic Risk Scores and Genetics in Psychiatry.
Ned H Kalin
American Journal of Psychiatry | VOL. 179
Ned H KalinNed H Kalin
01 Nov 2022
Serum concentrations of mood stabilizers are associated with memory, but not other cognitive domains in psychosis spectrum disorders; explorative analyses in a naturalistic setting.
Nils Eiel Steen ... Anja Vaskinn
International Journal of Bipolar Disorders | VOL. 4
Nils Eiel Steen, et. al.Nils Eiel Steen ... Anja Vaskinn
01 Dec 2016
View more papers

More From: CNS drugs

Paper Title
Journal
Date
Author
Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease.
Samuel Frank ...
CNS drugs | VOL. 39
Samuel Frank, et. al.Samuel Frank ...
01 Feb 2025
Comment on "A Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder"'.
Chenxi Wang ... Jin Shang
CNS drugs | VOL. 39
Chenxi Wang, et. al.Chenxi Wang ... Jin Shang
01 Feb 2025
Correction: Comment on "Effectiveness of Anti-Calcitonin Gene-Related Peptide Medication in Vestibular Migraine: A Retrospective Cohort Study in an Asian Population".
Xin Zhou ... Riyang Lin
CNS drugs | VOL. -
Xin Zhou, et. al.Xin Zhou ... Riyang Lin
01 Feb 2025
Correction: Efficacy of Cariprazine in the Psychosis Spectrum: A Systematic Review and Network Meta‑Analysis of Randomised Controlled Trials in Schizophrenia and Bipolar Disorder.
Livio Tarchi ... Giovanni Castellini
CNS drugs | VOL. 39
Livio Tarchi, et. al.Livio Tarchi ... Giovanni Castellini
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.